Details for New Drug Application (NDA): 017439
✉ Email this page to a colleague
NDA 017439 describes HYDROXYPROGESTERONE CAPROATE, which is a drug marketed by Allergan, Epic Pharma Llc, Aspen Global Inc, and Eugia Pharma, and is included in four NDAs. It is available from one supplier. Additional details are available on the HYDROXYPROGESTERONE CAPROATE profile page.
The generic ingredient in HYDROXYPROGESTERONE CAPROATE is hydroxyprogesterone caproate. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.
The generic ingredient in HYDROXYPROGESTERONE CAPROATE is hydroxyprogesterone caproate. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.
Summary for 017439
| Tradename: | HYDROXYPROGESTERONE CAPROATE |
| Applicant: | Allergan |
| Ingredient: | hydroxyprogesterone caproate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 125MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 250MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
